Pathological Laughter Following Intravenous Sodium Valproate
نویسندگان
چکیده
منابع مشابه
Pathological laughter following intravenous sodium valproate.
BACKGROUND Pathological laughter can be a sign of epilepsy, psychiatric illness, effect of toxins or psychotropic drugs or of structural brain disease. METHOD Case Studies. RESULT Two patients developed inappropriate uncontrollable laughter following intravenous sodium valproate for treatment of epilepsy. CONCLUSION Pathological laughter can be a side effect of intravenous sodium valproate.
متن کاملSodium valproate syrup, Sodium valproate syrup India, Sodium valproate syrup manufacturers India
Note:-We are committed to helping you find the right answers to your questions and concerns. However, this Report is not intended to give investment advice, promote the use of Taj Pharmaceuticals Ltd products or provide information on which to base medical treatment. If you have questions regarding any Taj Pharmaceuticals Ltd product or are experiencing a medical emergency, please consult your ...
متن کاملAltered cortical thickness following prenatal sodium valproate exposure
Prenatal exposure to sodium valproate (VPA) is associated with neurodevelopmental impairments. Cortical thickness was measured in 16 children exposed prenatally to VPA and 16 controls. We found increased left inferior frontal gyrus (IFG; BA45) and left pericalcarine sulcus (BA18) thickness, an association between VPA dose and right IFG thickness, and a close relationship between verbal skills a...
متن کاملLevetiracetam vs sodium valproate
2011;76;383 Neurology R. Shallcross, R.L. Bromley, B. Irwin, et al. sodium valproate Child development following in utero exposure : Levetiracetam vs May 5, 2011 This information is current as of http://www.neurology.org/content/76/4/383.full.html located on the World Wide Web at: The online version of this article, along with updated information and services, is rights reserved. Print ISSN: 00...
متن کاملSodium valproate and pregnancy.
Correspondence Sodium valproate and pregnancy Sir, We were presented with a baby born to a mother taking sodium valproate who wished to breast feed. There are no data on breast milk levels of sodium valproate; it is presumed from collateral evidence that some of the drug would pass across from maternal serum into the milk. Studies in animals given modest doses of sodium valproate during pregnan...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
سال: 1998
ISSN: 0317-1671,2057-0155
DOI: 10.1017/s0317167100034107